Distant Metastasis in Colorectal Cancer Patients-Do We Have New Predicting Clinicopathological and Molecular Biomarkers? A Comprehensive Review.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
24 Jul 2020
Historique:
received: 21 05 2020
revised: 21 07 2020
accepted: 22 07 2020
entrez: 30 7 2020
pubmed: 30 7 2020
medline: 18 2 2021
Statut: epublish

Résumé

Colorectal cancer (CRC) remains a serious health problem worldwide. Approximately half of patients will develop distant metastasis after CRC resection, usually with very poor prognosis afterwards. Because patient performance after distant metastasis surgery remains very heterogeneous, ranging from death within 2 years to a long-term cure, there is a clinical need for a precise risk stratification of patients to aid pre- and post-operative decisions. Furthermore, around 20% of identified CRC cases are at IV stage disease, known as a metastatic CRC (mCRC). In this review, we overview possible molecular and clinicopathological biomarkers that may provide prognostic and predictive information for patients with distant metastasis. These may comprise sidedness of the tumor, molecular profile and epigenetic characteristics of the primary tumor and arising metastatic CRC, and early markers reflecting cancer cell resistance in mCRC and biomarkers identified from transcriptome. This review discusses current stage in employment of these biomarkers in clinical practice as well as summarizes current experience in identifying predictive biomarkers in mCRC treatment.

Identifiants

pubmed: 32722130
pii: ijms21155255
doi: 10.3390/ijms21155255
pmc: PMC7432613
pii:
doi:

Substances chimiques

Biomarkers, Tumor 0

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Ministerstvo Zdravotnictví Ceské Republiky
ID : NV19-09-00237
Organisme : Progres
ID : Q40/06

Références

J Am Coll Surg. 2010 May;210(5):755-64, 764-6
pubmed: 20421045
Tumori. 2016 Dec 1;102(6):541-547
pubmed: 27647226
Clin Cancer Res. 2014 Oct 15;20(20):5322-30
pubmed: 25139339
Sci Transl Med. 2011 Sep 7;3(99):99ra86
pubmed: 21900593
Sci Rep. 2020 Jan 16;10(1):432
pubmed: 31949199
Br J Cancer. 2015 Dec 22;113(12):1730-4
pubmed: 26633560
Curr Probl Cancer. 2018 Nov;42(6):560-571
pubmed: 30100092
Nat Genet. 2015 Mar;47(3):209-16
pubmed: 25665006
J Cell Physiol. 2019 Jun;234(6):8192-8202
pubmed: 30317669
Syst Rev. 2017 Dec 19;6(1):262
pubmed: 29258583
Genome Biol. 2014 Aug 28;15(8):454
pubmed: 25164765
Cell. 2008 May 16;133(4):704-15
pubmed: 18485877
PLoS One. 2014 Mar 05;9(3):e90459
pubmed: 24599305
Cells. 2020 Jun 24;9(6):
pubmed: 32599894
Ann Surg. 2013 Oct;258(4):619-26; discussion 626-7
pubmed: 24018645
Cell Mol Gastroenterol Hepatol. 2017 Jan 20;3(2):163-173
pubmed: 28275683
Science. 2017 Jul 07;357(6346):55-60
pubmed: 28684519
Ann Coloproctol. 2019 Jun;35(3):109-117
pubmed: 31288500
Mutat Res. 2019 Jul - Sep;781:100-129
pubmed: 31416571
Nature. 2016 Jan 21;529(7586):289-90
pubmed: 26735017
Ann Oncol. 2014 Oct;25(10):1959-65
pubmed: 25185240
J Thorac Cardiovasc Surg. 1997 Jan;113(1):37-49
pubmed: 9011700
Cancer Discov. 2011 Nov;1(6):508-23
pubmed: 22586653
Br J Surg. 2012 Apr;99(4):477-86
pubmed: 22261895
Oncotarget. 2015 Feb 10;6(4):2549-61
pubmed: 25575824
Nat Med. 2015 Nov;21(11):1350-6
pubmed: 26457759
BMC Cancer. 2018 Jan 15;18(1):78
pubmed: 29334918
Ann Oncol. 2019 Jul 1;30(7):1096-1103
pubmed: 31038663
Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10158-63
pubmed: 17548814
Expert Opin Ther Targets. 2012 Mar;16(3):259-67
pubmed: 22385077
Oncotarget. 2015 Nov 17;6(36):38695-704
pubmed: 26497852
N Engl J Med. 2008 Oct 23;359(17):1757-65
pubmed: 18946061
Lancet. 2018 May 26;391(10135):2128-2139
pubmed: 29754777
J Clin Oncol. 2010 Mar 1;28(7):1254-61
pubmed: 20100961
Cancers (Basel). 2019 Jul 17;11(7):
pubmed: 31319569
Science. 2006 Sep 29;313(5795):1960-4
pubmed: 17008531
Clin J Oncol Nurs. 2014 Oct;18(5):581-5
pubmed: 25253112
Oncol Lett. 2015 Mar;9(3):1261-1265
pubmed: 25663894
Med Sci (Basel). 2018 Apr 13;6(2):
pubmed: 29652830
J Clin Invest. 2009 Jun;119(6):1420-8
pubmed: 19487818
J Clin Med. 2016 Mar 12;5(3):
pubmed: 26985909
Oncotarget. 2018 Apr 10;9(27):18698-18711
pubmed: 29721154
Cancer Lett. 2020 Feb 1;470:84-94
pubmed: 31610266
Ann Oncol. 2015 Jan;26(1):13-21
pubmed: 25115304
Anticancer Res. 2014 May;34(5):2061-8
pubmed: 24778007
Surg Oncol. 2012 Jun;21(2):103-7
pubmed: 21764578
PLoS One. 2017 Nov 28;12(11):e0188697
pubmed: 29182684
Br J Surg. 2015 Sep;102(10):1175-83
pubmed: 26206254
Br J Cancer. 2018 May;118(9):1217-1228
pubmed: 29610456
Clin Cancer Res. 2018 May 1;24(9):2214-2224
pubmed: 29203589
J Clin Oncol. 2019 Aug 1;37(22):1876-1885
pubmed: 31042420
Nature. 2012 Jun 28;486(7404):537-40
pubmed: 22722843
Clin Colorectal Cancer. 2005 Apr;5 Suppl 1:S38-46
pubmed: 15871765
N Engl J Med. 2015 Jun 25;372(26):2509-20
pubmed: 26028255
Curr Oncol. 2019 Nov;26(Suppl 1):S7-S15
pubmed: 31819705
Semin Oncol. 2007 Apr;34(2 Suppl 1):S7-11
pubmed: 17449352
Cancers (Basel). 2019 Oct 15;11(10):
pubmed: 31618962
JAMA Oncol. 2017 Feb 1;3(2):194-201
pubmed: 27722750
J Clin Oncol. 2008 Apr 1;26(10):1626-34
pubmed: 18316791
Mol Aspects Med. 2019 Oct;69:107-122
pubmed: 31189073
J Gastrointest Surg. 2018 Jul;22(7):1286-1296
pubmed: 29644557
Curr Cancer Drug Targets. 2017;17(5):456-466
pubmed: 28067178
Stem Cells Transl Med. 2012 Aug;1(8):592-603
pubmed: 23197865
Clin Cancer Res. 2018 Dec 1;24(23):5807-5814
pubmed: 29986850
Br J Cancer. 2013 Feb 19;108(3):668-75
pubmed: 23348520
Cancer Genet. 2012 Nov;205(11):545-51
pubmed: 23098991
Cancer Discov. 2018 Feb;8(2):164-173
pubmed: 29196463
Nature. 2007 Jan 4;445(7123):111-5
pubmed: 17122771
PLoS Genet. 2014 Mar 27;10(3):e1004271
pubmed: 24676216
Mol Cancer. 2019 Apr 2;18(1):75
pubmed: 30940145
Cancer Res. 2012 Apr 1;72(7):1878-89
pubmed: 22350410
Curr Opin Immunol. 2013 Apr;25(2):261-7
pubmed: 23579076
J Transl Med. 2012 Oct 03;10:205
pubmed: 23034130
BMC Cancer. 2016 Jul 26;16:539
pubmed: 27461012
Mol Oncol. 2014 Dec;8(8):1495-507
pubmed: 24962792
Cancer Discov. 2018 Jun;8(6):730-749
pubmed: 29510987
J Pathol. 2004 Sep;204(1):65-74
pubmed: 15307139
Clin Cancer Res. 2012 Feb 1;18(3):688-99
pubmed: 22173549
Int J Mol Sci. 2016 Dec 01;17(12):
pubmed: 27916952
Oncotarget. 2017 Sep 27;8(55):93856-93866
pubmed: 29212194
J Natl Cancer Inst. 2015 Feb 24;107(3):
pubmed: 25713148
Curr Probl Surg. 2017 Nov;54(11):554-602
pubmed: 29198365
Ann Surg. 1999 Sep;230(3):309-18; discussion 318-21
pubmed: 10493478
CA Cancer J Clin. 2019 Jan;69(1):7-34
pubmed: 30620402
Ann Gastroenterol Surg. 2018 Apr 17;2(3):167-175
pubmed: 29863162
Cancer Chemother Pharmacol. 2011 Sep;68(3):823-6
pubmed: 21553285
Clin Colorectal Cancer. 2015 Mar;14(1):1-10
pubmed: 25579803
Pathologe. 2018 Dec;39(Suppl 2):189-192
pubmed: 30267148
J Clin Oncol. 2012 Sep 20;30(27):3353-60
pubmed: 22915656
Cell. 2011 Oct 14;147(2):275-92
pubmed: 22000009
J Cell Physiol. 2012 Jun;227(6):2686-93
pubmed: 21898409
Int J Mol Sci. 2018 Oct 26;19(11):
pubmed: 30373199
Ther Adv Med Oncol. 2016 Jan;8(1):57-84
pubmed: 26753006
Clin Cancer Res. 2016 May 15;22(10):2575-82
pubmed: 26733613
N Engl J Med. 2019 Oct 24;381(17):1632-1643
pubmed: 31566309
Curr Opin Cell Biol. 2003 Dec;15(6):740-6
pubmed: 14644200
Clin Cancer Res. 2003 Aug 1;9(8):2898-903
pubmed: 12912934
Bull Cancer. 2019 Feb;106(2):119-128
pubmed: 30713006
Signal Transduct Target Ther. 2020 Mar 20;5(1):22
pubmed: 32296018
Oncologist. 2014 May;19(5):568-73
pubmed: 24718513
World J Gastroenterol. 2014 Apr 14;20(14):3719-37
pubmed: 24744570
Nat Commun. 2017 May 31;8:15107
pubmed: 28561063
Gastroenterology. 2014 Sep;147(3):637-45
pubmed: 24859205
Gastroenterology. 2015 Oct;149(5):1177-1190.e3
pubmed: 26216840
Int J Cancer. 2020 Jul 1;147(1):285-296
pubmed: 31970760
Med Oncol. 2013 Mar;30(1):356
pubmed: 23322518
Ther Adv Med Oncol. 2011 Jan;3(1):43-52
pubmed: 21789155
Genes Chromosomes Cancer. 2011 May;50(5):307-12
pubmed: 21305640
Curr Opin Biotechnol. 2007 Oct;18(5):460-6
pubmed: 18023337
J Clin Oncol. 2018 Mar 10;36(8):773-779
pubmed: 29355075
BMC Cancer. 2018 Jul 20;18(1):752
pubmed: 30029640
Nat Med. 2014 May;20(5):548-54
pubmed: 24705333
Nat Rev Cancer. 2018 Apr;18(4):211-223
pubmed: 29422598
Ann Surg. 2008 Jan;247(1):125-35
pubmed: 18156932
Clin Cancer Res. 2015 Oct 15;21(20):4586-96
pubmed: 26085511
Ann Surg. 2008 Feb;247(2):282-7
pubmed: 18216534
Ann Surg. 2007 Aug;246(2):183-91
pubmed: 17667495
Proc Natl Acad Sci U S A. 2011 May 10;108(19):7950-5
pubmed: 21498687
Sci Transl Med. 2014 Mar 19;6(228):228ra37
pubmed: 24648340
Immunity. 2016 Mar 15;44(3):698-711
pubmed: 26982367
Ann Oncol. 2016 Aug;27(8):1539-46
pubmed: 27177863
Br J Surg. 2014 Jun;101(7):856-66
pubmed: 24817653
Front Med (Lausanne). 2018 Aug 31;5:234
pubmed: 30234115
Sci Transl Med. 2014 Feb 19;6(224):224ra24
pubmed: 24553385
Clin Cancer Res. 2011 Mar 1;17(5):1122-30
pubmed: 21239505
World J Gastroenterol. 2015 Jun 7;21(21):6470-8
pubmed: 26074686
Sci Rep. 2017 Jan 19;7:40737
pubmed: 28102343
Medicine (Baltimore). 2019 Aug;98(32):e16709
pubmed: 31393377
Oncology. 2013;84(1):14-21
pubmed: 23076023
Front Pharmacol. 2020 Jun 17;11:904
pubmed: 32625096
Cancer Manag Res. 2020 Mar 04;12:1621-1630
pubmed: 32184665
N Engl J Med. 2005 Dec 22;353(25):2654-66
pubmed: 16371631
Cancer Genomics Proteomics. 2019 May-Jun;16(3):207-219
pubmed: 31018951
Oncoimmunology. 2015 Jun 9;5(1):e1057388
pubmed: 26942067
Genome Biol. 2018 Sep 25;19(1):142
pubmed: 30253799
J Cell Sci. 2010 Jul 15;123(Pt 14):2357-68
pubmed: 20592182
World J Gastroenterol. 2011 Sep 28;17(36):4067-75
pubmed: 22039320
Clin Cancer Res. 2014 Jun 15;20(12):3338-47
pubmed: 24771647
Science. 1976 Oct 1;194(4260):23-8
pubmed: 959840
J Pathol. 2014 Jan;232(2):199-209
pubmed: 24122236
Clin Cancer Res. 2015 Mar 15;21(6):1258-66
pubmed: 25770293
J Gastroenterol Hepatol. 2018 Jan;33(1):209-225
pubmed: 28608993
Pharmacol Ther. 2020 Feb;206:107447
pubmed: 31756363
Cell Stem Cell. 2010 Jun 4;6(6):603-15
pubmed: 20569697
Ann Surg. 2019 Nov;270(5):799-805
pubmed: 31634180
Curr Cancer Drug Targets. 2018;18(5):421-429
pubmed: 28183254
Lancet Gastroenterol Hepatol. 2018 Sep;3(9):635-643
pubmed: 30042065
Ann Surg. 1987 Mar;205(3):264-70
pubmed: 3827362
Arch Surg. 1984 Sep;119(9):1067-72
pubmed: 6383272
Sci Rep. 2016 Jul 07;6:29023
pubmed: 27383461
Eur J Cancer. 2015 May;51(7):791-9
pubmed: 25797355
Int J Colorectal Dis. 2016 Sep;31(9):1655-6
pubmed: 27129852
PLoS One. 2015 May 14;10(5):e0126670
pubmed: 25974029
Cell Biosci. 2014 Nov 25;4:69
pubmed: 25937891
Cancers (Basel). 2020 Jan 30;12(2):
pubmed: 32019056
Nature. 2012 Jul 18;487(7407):330-7
pubmed: 22810696
PLoS One. 2011 Feb 24;6(2):e16636
pubmed: 21383983
Br J Surg. 2001 Feb;88(2):165-75
pubmed: 11167863
J Clin Oncol. 2009 Dec 10;27(35):5944-51
pubmed: 19858404
J Am Coll Surg. 1999 Sep;189(3):291-9
pubmed: 10472930
J Natl Compr Canc Netw. 2013 Sep;11 Suppl 4:S18-27
pubmed: 24158967
Ann Oncol. 2016 Aug;27(8):1386-422
pubmed: 27380959
J Transl Med. 2012 Jan 03;10:1
pubmed: 22214470
Nat Rev Clin Oncol. 2017 Sep;14(9):531-548
pubmed: 28252003
Mol Cancer. 2017 Jul 6;16(1):116
pubmed: 28683746
J Natl Cancer Inst. 2017 Dec 1;109(12):
pubmed: 29370427
JAMA Oncol. 2017 Feb 1;3(2):211-219
pubmed: 27787550
J Clin Oncol. 2010 May 20;28(15):2556-64
pubmed: 20385995
Clin Exp Metastasis. 2012 Oct;29(7):737-46
pubmed: 22669542
J Clin Oncol. 2008 Jan 20;26(3):374-9
pubmed: 18202412
JAMA Oncol. 2018 Apr 12;4(4):e175245
pubmed: 29423521
Ann Oncol. 2017 Aug 1;28(8):1713-1729
pubmed: 28407110
Cancer Lett. 2013 Nov 28;341(1):97-104
pubmed: 23089245
Gastroenterology Res. 2018 Aug;11(4):264-273
pubmed: 30116425
Clin Cancer Res. 2018 Feb 15;24(4):794-806
pubmed: 29242316
Transl Oncol. 2018 Oct;11(5):1220-1224
pubmed: 30086420
Clin Cancer Res. 2019 Jan 1;25(1):134-141
pubmed: 30108104
Surg Oncol. 2018 Jun;27(2):280-288
pubmed: 29937183
CA Cancer J Clin. 2020 May;70(3):145-164
pubmed: 32133645
Int J Mol Sci. 2018 Nov 23;19(12):
pubmed: 30477151
Mol Cancer. 2018 Oct 5;17(1):145
pubmed: 30290811
Int J Mol Sci. 2018 Oct 03;19(10):
pubmed: 30282914
J Natl Cancer Inst. 2015 Nov 12;108(1):
pubmed: 26563355
Oncotarget. 2016 Mar 1;7(9):10023-36
pubmed: 26840260
PLoS One. 2008 Jun 18;3(6):e2428
pubmed: 18560594
Curr Treat Options Oncol. 2015 Jul;16(7):30
pubmed: 26031544
Oncotarget. 2019 Mar 1;10(18):1704-1715
pubmed: 30899442
BMC Cancer. 2014 Feb 05;14:64
pubmed: 24495478
Clin Cancer Res. 2016 Aug 15;22(16):4057-66
pubmed: 26994146
Science. 2017 Jul 28;357(6349):409-413
pubmed: 28596308
J Clin Med. 2018 Nov 18;7(11):
pubmed: 30453668
Cell Biol Int. 2020 Feb;44(2):368-380
pubmed: 31579983
Virchows Arch. 2014 Mar;464(3):379-91
pubmed: 24487787
Expert Rev Gastroenterol Hepatol. 2019 Oct;13(10):919-931
pubmed: 31475851
Cancer. 2011 May 1;117(9):1847-54
pubmed: 21509761
Clin Exp Metastasis. 2011 Dec;28(8):751-63
pubmed: 21750907
Clin Cancer Res. 2014 Sep 1;20(17):4613-24
pubmed: 25013125
Br J Cancer. 2015 Jun 9;112(12):1888-94
pubmed: 25989278
N Engl J Med. 2013 Sep 12;369(11):1023-34
pubmed: 24024839
Cancer. 2018 Apr 1;124(7):1358-1373
pubmed: 29338072
Am J Surg Pathol. 2015 Aug;39(8):1140-7
pubmed: 25786087

Auteurs

Stanislav Filip (S)

Department of Oncology and Radiotherapy, Charles University, Faculty of Medicine in Hradec Kralove, Šimkova 870, 50001 Hradec Králové, Czech Republic.

Veronika Vymetalkova (V)

Department of Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Videnska 1083, 14220 Prague, Czech Republic.
Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 1655, 32300 Pilsen, Czech Republic.
Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Albertov 4, 12800 Prague, Czech Republic.

Jiri Petera (J)

Department of Oncology and Radiotherapy, Charles University, Faculty of Medicine in Hradec Kralove, Šimkova 870, 50001 Hradec Králové, Czech Republic.

Ludmila Vodickova (L)

Department of Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Videnska 1083, 14220 Prague, Czech Republic.
Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 1655, 32300 Pilsen, Czech Republic.
Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Albertov 4, 12800 Prague, Czech Republic.

Ondrej Kubecek (O)

Department of Oncology and Radiotherapy, Charles University, Faculty of Medicine in Hradec Kralove, Šimkova 870, 50001 Hradec Králové, Czech Republic.

Stanislav John (S)

Department of Oncology and Radiotherapy, Charles University, Faculty of Medicine in Hradec Kralove, Šimkova 870, 50001 Hradec Králové, Czech Republic.

Filip Cecka (F)

Department of Surgery, University Hospital in Hradec Kralove, Sokolská 581, 50005 Hradec Králové, Czech Republic.

Marketa Krupova (M)

The Fingerland Department of Pathology, University Hospital in Hradec Kralove, Sokolská 581, 50005 Hradec Králové, Czech Republic.

Monika Manethova (M)

The Fingerland Department of Pathology, University Hospital in Hradec Kralove, Sokolská 581, 50005 Hradec Králové, Czech Republic.

Klara Cervena (K)

Department of Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Videnska 1083, 14220 Prague, Czech Republic.
Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Albertov 4, 12800 Prague, Czech Republic.

Pavel Vodicka (P)

Department of Molecular Biology of Cancer, Institute of Experimental Medicine of the Czech Academy of Sciences, Videnska 1083, 14220 Prague, Czech Republic.
Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 1655, 32300 Pilsen, Czech Republic.
Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, Albertov 4, 12800 Prague, Czech Republic.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH